Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in mang
- 1 March 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 112 (3) , 285-290
- https://doi.org/10.1111/j.1365-2133.1985.tb04855.x
Abstract
Platelet activating factor (Paf-acether, AGEPC) is a family of ether-linked phospholipids known to be released from a range of inflammatory cell types. In vitro and in experimental animals, it seems to be a mediator of inflammation, and intradermal injection of Paf-acether in man elicits a biphasic inflammatory response, reminiscent of the dual response to allergen in sensitized individuals. In the present study, cutaneous histology was assessed in sequential skin biopsies from six normal volunteers after intradermal injection of 200 or 800 pmol Paf-acether. Paf-acether (200 pmol) induced intravascular accumulation of neutrophils, accompanied by a p erivascular mixed cellular infiltrate which was composed predominantly of neutrophils at 4 and 12 hours, and lymphocytes and histiocytes at 24 hours. Control injections of lyso-Paf and normal saline induced no noteworthy histological changes. Paf-acether (800 pmol) resulted in vessel destruction, gross endothelial swelling and a perivascular infiltrate of mononuclear cells and neutrophils, accompanied by occasional evidence of leucocytoclasis. By virtue of its ability to induce inflammatory cell accumulation in human skin, Paf-acether should be considered as a potential mediator of inflammatory disorders such as psoriasis.This publication has 15 references indexed in Scilit:
- The plasma protein extravasation response to PAF-acether is independent of platelet accumulationInflammation Research, 1984
- Inflammatory characteristics of platelet activating factor (PAF-acether) in human skinBritish Journal of Dermatology, 1984
- Inflammatory actions of platelet activating factor (Paf‐acether) in guinea‐pig skinBritish Journal of Pharmacology, 1983
- CV-3988 - A specific antagonist of platelet activating factor (PAF)Life Sciences, 1983
- Pharmacokinetic study of PAF-acether preliminary results after the intravenous administration of a3H-labelled product to the rabbitInflammation Research, 1982
- Effect of synthetic PAF-acether on human neutrophil functionInflammation Research, 1981
- Induction of late cutaneous reactions by skin-blister fluid from allergen-tested and normal skinJournal of Allergy and Clinical Immunology, 1981
- Mediators of Immune-Complex-Induced Aggregation of Polymorphonuclear NeutrophilsInternational Archives of Allergy and Immunology, 1981
- Platelet activating factor (PAF‐acether): total synthesis of 1‐O‐octadecyl 2‐O‐acetyl sn‐glycero‐3‐phosphoryl cholineFEBS Letters, 1980
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972